Navigation Links
Catalysis takes center stage at chemistry conference
Date:8/19/2008

RICHLAND, Wash. Scientists can learn how advances in catalysis are addressing real-world energy problems and expanding research horizons at an upcoming symposium at the 236th American Chemical Society national meeting in Philadelphia, Penn. The scientific community is honoring the contributions of the late Mike White at the symposium, which will be held from August 19-21.

"Catalysis is particularly important when it comes to energy supply," said PNNL chemist Daniel DuBois. "Mike was very aware of and concerned about the big energy problem, and the role of catalysis in the solution."

Catalysts are substances that facilitate chemical reactions but are not changed by them. Catalysts change the rate at which chemical bonds are formed and broken. Researchers can use catalysts to control the rates of chemical reactions, increasing the amounts of desirable products and reducing the amounts of undesirable ones. As a result, understanding how catalysts work is important to many industrial processes including petroleum refining and production of various chemicals.

"This symposium is our way of honoring Mike and the impact he had on our personal and professional lives," said Mike Henderson, lead organizer of the symposium who studied under White and worked with him at PNNL's Institute for Interfacial Catalysis http://iic.pnl.gov/.

One way PNNL scientists are harnessing the power of catalysis is through hydrogen oxidation and production, two processes necessary for fuel cells to function. So far, however, such chemical conversions are expensive, requiring the precious metal platinum. DuBois is exploring how to design alternative catalysts that use inexpensive metals such as nickel and cobalt.

"We are working to find cheaper ways to make these processes happen," said DuBois. "In order to maximize catalyst performance, we have to understand how the process works."

White, a Robert A. Welch Cha
'/>"/>

Contact: Mary Beckman
mary.beckman@pnl.gov
509-375-3688
DOE/Pacific Northwest National Laboratory
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. The key to unlocking the secret of highly specific DNAzyme catalysis
2. Frog study takes leaf out of natures book
3. Researchers discover critical detail of cellular defense against genetic mistakes
4. EuroDYNA takes lid off the genome
5. Buckminster Fuller takes on big coal
6. NOAA takes first broad look at soot from ships
7. Georgia Tech/Emory Center to study origin of life
8. Woods Hole Research Center to lead undergraduate initiative in the Siberian Arctic
9. $10 million gift to support cutting-edge epigenome center at USC
10. 3 Columbia University Medical Center faculty elected to Institute of Medicine
11. NHGRI funds new Centers for Excellence in Ethical, Legal and Social Implications Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ers, red deer have been caught in the hunters, sig... more than decorative. They are lethal weapons tha... from The University of York, UK, has been intrigu...alf a century and has become fascinated by the mec...ng collaboration with Tomas Landete-Castillejos at...
(Date:11/26/2009)...phylococcus Aureus ) and other drug-resistant bact...asma prototype devices have been developed to offe...ktails. , Two prototype devices have been develo...n (e.g. hands and feet) in hospitals and public sp...another to shoot bacteria-killing agents into infe...
(Date:11/25/2009)... Cell Death Research Laboratory in the University ... the prestigious Johnson & Johnson Focused Funding...in cell damage in Parkinson,s disease. The award, ...t of innovation and excellence in science, was ann...his month at an event at the Hyatt Regency Hotel i...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New Media Led Effort Responds to AIDS Crisis in Black America 50086 1New Media Led Effort Responds to AIDS Crisis in Black America 50086 2New Media Led Effort Responds to AIDS Crisis in Black America 50086 3New Media Led Effort Responds to AIDS Crisis in Black America 50086 4New Media Led Effort Responds to AIDS Crisis in Black America 50086 5New Media Led Effort Responds to AIDS Crisis in Black America 50086 6Abused Kids Face Higher Cancer Risk 50083 1Abused Kids Face Higher Cancer Risk 50083 2U M study finds voice box can be preserved even with the largest cancers 50080 1U M study finds voice box can be preserved even with the largest cancers 50080 2
...gy infrastructure for researching and developing n...e industry hundreds of millions of dollars annuall... the National Institute of Standards and Technolog...T, the studys authors found that over the last two...ted from small-molecule chemicals to large-molecul...
...archers contributed to a national effort to sequen...hat will help advance research in a broad range of... to understanding a variety of human diseases. , ...ectionately as Chlamy, has long fascinated scienti...s that retains characteristics of both. Like green...
...greatly improves the ability to separate global wa...e gas is prepared for use, according to engineers ...yzed the new plastics performance. , Like a spong...astic permits carbon dioxide or other small molecu...t, while impeding natural gas (methane) movement t...
Other Biology News:Biopharmaceutical infrastructure key to lower drug development costs 2'Chlamy' genome holds clues for renewable energy, the environment and human health 2New membrane strips carbon dioxide from natural gas faster and better 2New membrane strips carbon dioxide from natural gas faster and better 3
(Date:11/30/2009)...RK, Nov. 30 The Michael... today announced $1.5 million in total awards to s...isease-modifying therapies for Parkinson,s disease...hes to Drug Discovery for Parkinson,s Disease pro...on, plc (NYSE: ELN ), a neuroscience-based biote...
(Date:11/30/2009)...STERDAM, November 30 Biopharmaceut...e first patients have been enrolled in its,multina...The study is,designed to show reduction in transpl...ng an allogeneic stem cell transplantation with a ... patients eligible for an allogeneic,stem cell tra...
(Date:11/30/2009)...LLE, Md., Nov. 30 Novava...mpleted enrollment in the Phase II clinical study ...ommended strains) VLP vaccine candidate in healthy...This randomized, double-blind, active-controlled s...unogenicity of two different doses (15 mcg and 60 ...
(Date:11/30/2009)...EATTLE, Nov. 30 Cell The...nced today that its new class of platinum-based an...rated a stronger anti-tumor potency and activity c...ounds as well as the ability to overcome cisplatin...e presented in a paper titled "Novel Bis-platinum ...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3
...ED FOR TUESDAY, OCTOBER 28, SAN DIEGO, Oct. 22 N...ced today that the Company will report its third,q...ket closes on Tuesday,October 28, 2008. Neurocrine...iscuss its financial results and provide a Company...0 p.m. Eastern Time (2:00 p.m. Pacific,Time)., Pa...
...Inc.,(Nasdaq: TELK ) announced that its 2008 thir... on Wednesday, November 5, 2008 at 4:30 p.m. Easte...ease earlier that day of the,company,s financial r...008., The conference call will be accessible via ...lephone at 800-398-9367 or 612-332-7517. An,archiv...
...r Systems, Inc., a,medical device company developi... announced today that it has signed an agreement w...ercialize StemCor,s proprietary System,for the har...com/cgi-bin/prnh/20071030/STEMCORSYSTEMSLOGO ), S...spira will manage,the clinical trial program, lead...
Other Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2008 Financial Results 2StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists 2StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists 3
Goat Anti-Human SCP3 / SYCP3 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-Human ADH5 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human Rad1 Monoclonal Antibody, Unconjugated, Clone 33 from R&D Systems
Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen)
Biology Products: